Wednesday, September 9, 2026
27.8 C
Bengaluru

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial strategy, supply chain management, procurement, operations, and sustainability, Rajesh brings a strong track record of driving transformation and growth across global markets.

Before joining ACG, Rajesh held several leadership positions at EPL Ltd. (Essel Propack Ltd.), where he led global supply chain and sustainability initiatives across multiple countries. His career also includes significant leadership experience at BASF India and Asian Paints, where he contributed to large-scale initiatives spanning supply chain transformation, strategic procurement, operational excellence, digitalisation, inventory optimisation, and cost transformation.

In his new role as Chief Commercial Officer, Rajesh will lead ACG’s global commercial strategy, strengthen strategic partnerships, support market expansion, and drive initiatives focused on commercial excellence and sustainable growth.

His diverse experience across manufacturing, chemicals, packaging, and consumer-focused industries positions him to bring a broad business perspective as ACG continues to strengthen its global presence across pharmaceutical and nutraceutical manufacturing solutions.

MedicinMan congratulates Rajesh Bhogavalli on this new leadership role and wishes him continued success.

Hot this week

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

Topics

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....
spot_img

Related Articles

spot_imgspot_img